William C. Klindt, MD
Child & Adolescent Psychiatry · Los Gatos
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Has dropped Medicare — you would pay privately
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Klindt’s office at (408) 690-1573 to ask if they take your plan before you enroll.
California Medical Board record
Licence G69058 · Current
Licensed to practise in California · since 1990 · expires 2028-06-30 · Oral Roberts University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
$41,631
Pharmacies billed $41,631 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 477) in 2024. At or below the middle of the specialty; the typical neuropsychiatry clinician is at 0%.
435 generic and 42 brand-name prescriptions · $41,631 in drug cost · 11 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Trintellix | 20 | $16,281 | $814 |
| Desvenlafaxine Succinate Er | 14 | $1,178 | $84 |
| Dextroamphetamine-Amphetamine | 29 | $847 | $29 |
| Methylphenidate Er | 11 | $778 | $71 |
| Methylphenidate | 18 | $757 | $42 |
See all 20 drugs
| Trintellix | 20 | $16,281 | $814 |
| Desvenlafaxine Succinate Er | 14 | $1,178 | $84 |
| Dextroamphetamine-Amphetamine | 29 | $847 | $29 |
| Methylphenidate Er | 11 | $778 | $71 |
| Methylphenidate | 18 | $757 | $42 |
| Fluvoxamine Maleate | 33 | $746 | $23 |
| Mirtazapine | 11 | $546 | $50 |
| Olanzapine | 11 | $397 | $36 |
| Bupropion Xl | 21 | $394 | $19 |
| Lorazepam | 32 | $380 | $12 |
| Trazodone | 24 | $345 | $14 |
| Duloxetine | 19 | $306 | $16 |
| Aripiprazole | 14 | $294 | $21 |
| Buspirone | 18 | $214 | $12 |
| Clonazepam | 17 | $121 | $7 |
| Zolpidem | 24 | $117 | $5 |
| Guanfacine Hcl Er | 13 | $89 | $7 |
| Bupropion Hcl Sr | 12 | $44 | $4 |
| Diazepam | 15 | $29 | $2 |
| Quetiapine | 11 | $27 | $2 |
Year by year
| 2024 | 477 | 30 | 0% (0) | 9% | $41,631 |
| 2023 | 501 | 27 | 0% (0) | 9% | $39,757 |
| 2022 | 473 | 25 | 0% (0) | 10% | $32,764 |
| 2021 | 394 | 22 | 0% (0) | 11% | $37,601 |
| 2020 | 373 | 21 | 0% (0) | 12% | $41,625 |
| 2019 | 338 | 20 | 0% (0) | 10% | $17,548 |
| 2018 | 300 | 20 | 0% (0) | 20% | $45,122 |
| 2017 | 345 | 20 | 0% (0) | 17% | $50,670 |
| 2016 | 460 | 23 | 0% (0) | 13% | $51,478 |
| 2015 | 480 | 23 | 0% (0) | 14% | $46,195 |
| 2014 | 414 | 21 | 0% (0) | 18% | $44,697 |
| 2013 | 355 | 18 | None | 29% | $40,968 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 19 drugs
| Trintellix | 16 | $11,826 | $739 |
| Buspirone | 31 | $1,167 | $38 |
| Dextroamphetamine-Amphetamine | 16 | $998 | $62 |
| Duloxetine | 31 | $783 | $25 |
| Lorazepam | 26 | $520 | $20 |
| Fluvoxamine Maleate | 36 | $451 | $13 |
| Bupropion Xl | 41 | $431 | $11 |
| Trazodone | 26 | $354 | $14 |
| Desvenlafaxine Succinate Er | 14 | $331 | $24 |
| Methylphenidate | 16 | $281 | $18 |
| Clonazepam | 22 | $278 | $13 |
| Lamotrigine | 15 | $258 | $17 |
| Aripiprazole | 16 | $217 | $14 |
| Escitalopram | 12 | $128 | $11 |
| Venlafaxine Hcl Er | 16 | $118 | $7 |
| Alprazolam | 11 | $91 | $8 |
| Citalopram Hbr | 11 | $64 | $6 |
| Diazepam | 11 | $54 | $5 |
| Zolpidem | 26 | $45 | $2 |
2022: 14 drugs
| Duloxetine | 26 | $1,098 | $42 |
| Dextroamphetamine-Amphetamine | 21 | $936 | $45 |
| Bupropion Xl | 37 | $831 | $22 |
| Methylphenidate Er | 12 | $751 | $63 |
| Methylphenidate | 18 | $721 | $40 |
| Buspirone | 28 | $696 | $25 |
| Fluvoxamine Maleate | 34 | $637 | $19 |
| Bupropion Hcl Sr | 18 | $473 | $26 |
| Lorazepam | 34 | $423 | $12 |
| Trazodone | 21 | $324 | $15 |
| Olanzapine | 11 | $283 | $26 |
| Lamotrigine | 20 | $273 | $14 |
| Clonazepam | 22 | $130 | $6 |
| Zolpidem | 24 | $39 | $2 |
2021: 11 drugs
| Bupropion Xl | 35 | $1,423 | $41 |
| Dextroamphetamine-Amphetamine | 21 | $995 | $47 |
| Fluvoxamine Maleate | 32 | $938 | $29 |
| Methylphenidate Er | 12 | $838 | $70 |
| Buspirone | 26 | $619 | $24 |
| Bupropion Hcl Sr | 12 | $487 | $41 |
| Lamotrigine | 23 | $329 | $14 |
| Trazodone | 18 | $303 | $17 |
| Lorazepam | 17 | $230 | $14 |
| Clonazepam | 21 | $135 | $6 |
| Zolpidem | 23 | $45 | $2 |
2020: 12 drugs
| Prozac | 12 | $11,564 | $964 |
| Methylphenidate Er | 11 | $2,080 | $189 |
| Bupropion Xl | 25 | $1,351 | $54 |
| Dextroamphetamine-Amphetamine | 18 | $796 | $44 |
| Fluvoxamine Maleate | 27 | $464 | $17 |
| Lamotrigine | 23 | $369 | $16 |
| Buspirone | 21 | $356 | $17 |
| Clonazepam | 23 | $345 | $15 |
| Duloxetine | 22 | $344 | $16 |
| Lorazepam | 15 | $194 | $13 |
| Trazodone | 28 | $151 | $5 |
| Zolpidem | 15 | $35 | $2 |
2019: 14 drugs
| Dextroamphetamine-Amphet Er | 18 | $1,311 | $73 |
| Dextroamphetamine-Amphetamine | 20 | $1,154 | $58 |
| Bupropion Xl | 21 | $1,064 | $51 |
| Desvenlafaxine Succinate Er | 12 | $892 | $74 |
| Duloxetine | 26 | $387 | $15 |
| Fluvoxamine Maleate | 16 | $321 | $20 |
| Buspirone | 27 | $248 | $9 |
| Trazodone | 25 | $199 | $8 |
| Lorazepam | 15 | $187 | $12 |
| Lamotrigine | 18 | $160 | $9 |
| Clonazepam | 13 | $129 | $10 |
| Quetiapine | 14 | $105 | $8 |
| Bupropion Hcl Sr | 11 | $37 | $3 |
| Escitalopram | 12 | $21 | $2 |
2018: 14 drugs
| Pristiq | 12 | $4,636 | $386 |
| Dextroamphetamine-Amphet Er | 14 | $907 | $65 |
| Bupropion Xl | 11 | $726 | $66 |
| Duloxetine | 28 | $536 | $19 |
| Zonisamide | 12 | $271 | $23 |
| Buspirone | 17 | $230 | $14 |
| Quetiapine | 18 | $223 | $12 |
| Fluvoxamine Maleate | 16 | $213 | $13 |
| Bupropion Hcl Sr | 12 | $152 | $13 |
| Trazodone | 23 | $118 | $5 |
| Fluoxetine | 12 | $66 | $6 |
| Clonazepam | 13 | $62 | $5 |
| Alprazolam | 13 | $55 | $4 |
| Lorazepam | 12 | $47 | $4 |
2017: 14 drugs
| Abilify | 11 | $6,821 | $620 |
| Buspirone | 24 | $1,311 | $55 |
| Dextroamphetamine-Amphetamine | 15 | $963 | $64 |
| Duloxetine | 34 | $572 | $17 |
| Bupropion Xl | 13 | $335 | $26 |
| Zonisamide | 12 | $271 | $23 |
| Fluvoxamine Maleate | 14 | $175 | $13 |
| Trazodone | 24 | $154 | $6 |
| Quetiapine | 15 | $122 | $8 |
| Clonazepam | 17 | $76 | $4 |
| Bupropion Hcl Sr | 14 | $73 | $5 |
| Fluoxetine | 12 | $66 | $6 |
| Lorazepam | 12 | $40 | $3 |
| Alprazolam | 13 | $23 | $2 |
2016: 18 drugs
| Pristiq | 12 | $3,510 | $292 |
| Duloxetine | 22 | $1,380 | $63 |
| Dextroamphetamine-Amphetamine | 17 | $739 | $43 |
| Buspirone | 39 | $528 | $14 |
| Trazodone | 45 | $340 | $8 |
| Zonisamide | 13 | $294 | $23 |
| Risperidone | 16 | $257 | $16 |
| Fluvoxamine Maleate | 16 | $222 | $14 |
| Olanzapine | 15 | $182 | $12 |
| Quetiapine | 12 | $144 | $12 |
| Fluoxetine | 17 | $140 | $8 |
| Sertraline | 15 | $138 | $9 |
| Benztropine Mesylate | 17 | $136 | $8 |
| Clonazepam | 21 | $89 | $4 |
| Diazepam | 11 | $83 | $8 |
| Bupropion Hcl Sr | 12 | $73 | $6 |
| Alprazolam | 14 | $61 | $4 |
| Lorazepam | 12 | $36 | $3 |
2015: 20 drugs
| Abilify | 12 | $5,385 | $449 |
| Brintellix | 15 | $3,901 | $260 |
| Duloxetine | 20 | $2,420 | $121 |
| Dextroamphetamine-Amphetamine | 18 | $768 | $43 |
| Fluvoxamine Maleate | 17 | $374 | $22 |
| Zonisamide | 12 | $274 | $23 |
| Buspirone | 36 | $249 | $7 |
| Quetiapine | 17 | $220 | $13 |
| Bupropion Hcl Sr | 18 | $209 | $12 |
| Trazodone | 38 | $187 | $5 |
| Risperidone | 11 | $187 | $17 |
| Olanzapine | 16 | $183 | $11 |
| Sertraline | 15 | $161 | $11 |
| Clonazepam | 27 | $155 | $6 |
| Benztropine Mesylate | 16 | $128 | $8 |
| Fluoxetine | 17 | $120 | $7 |
| Topiramate | 18 | $103 | $6 |
| Lorazepam | 12 | $79 | $7 |
| Citalopram Hbr | 14 | $77 | $5 |
| Alprazolam | 22 | $64 | $3 |
2014: 16 drugs
| Zonegran | 12 | $14,049 | $1,171 |
| Abilify | 13 | $5,166 | $397 |
| Duloxetine | 15 | $2,851 | $190 |
| Pristiq Er | 13 | $2,732 | $210 |
| Amphetamine Salt Combo | 17 | $1,296 | $76 |
| Fluvoxamine Maleate | 30 | $705 | $24 |
| Olanzapine | 14 | $654 | $47 |
| Zonisamide | 12 | $566 | $47 |
| Buspirone | 27 | $235 | $9 |
| Clonazepam | 25 | $209 | $8 |
| Citalopram Hbr | 30 | $177 | $6 |
| Trazodone | 29 | $161 | $6 |
| Sertraline | 16 | $153 | $10 |
| Benztropine Mesylate | 14 | $101 | $7 |
| Fluoxetine | 15 | $83 | $6 |
| Lorazepam | 18 | $77 | $4 |
2013: 13 drugs
| Zonegran | 12 | $11,098 | $925 |
| Abilify | 12 | $4,378 | $365 |
| Amphetamine Salt Combo | 13 | $2,144 | $165 |
| Fluvoxamine Maleate | 39 | $834 | $21 |
| Zonisamide | 12 | $312 | $26 |
| Sertraline | 23 | $304 | $13 |
| Clonazepam | 25 | $229 | $9 |
| Buspirone | 19 | $153 | $8 |
| Trazodone | 25 | $142 | $6 |
| Topiramate | 12 | $139 | $12 |
| Citalopram Hbr | 17 | $126 | $7 |
| Fluoxetine | 12 | $103 | $9 |
| Lorazepam | 13 | $79 | $6 |
Money from drug and device companies
$1,896 in 2025
| 2025 | 9 | 78 | None | $1,896 |
| 2024 | 14 | 60 | None | $1,531 |
| 2023 | 12 | 53 | None | $1,114 |
| 2022 | 11 | 75 | None | $1,373 |
| 2021 | 11 | 48 | None | $938 |
| 2020 | 10 | 49 | None | $790 |
| 2019 | 10 | 37 | None | $832 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Vraylar | $430 | 26 payments
|
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Caplyta | $426 | 14 payments
|
| Vanda Pharmaceuticals | Fanapt | $369 | 15 payments
|
| Alkermes | Lybalvi | $212 | 5 payments
|
| Axsome Therapeutics | Auvelity | $185 | 7 payments
|
| Otsuka America Pharmaceutical | Rexulti | $104 | 4 payments
|
See all 78 published payments
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-12-22 | Caplyta | $35 |
| Vanda Pharmaceuticals | Meals · 2025-12-18 | Fanapt | $2 |
| Vanda Pharmaceuticals | Meals · 2025-12-18 | Fanapt | $11 |
| Otsuka America Pharmaceutical | Meals · 2025-12-16 | Rexulti | $26 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-12-08 | Trintellix | $30 |
| Vanda Pharmaceuticals | Meals · 2025-12-03 | Fanapt | $121 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-12-01 | Caplyta | $34 |
| Vanda Pharmaceuticals | Meals · 2025-11-24 | Fanapt | $35 |
| Otsuka America Pharmaceutical | Meals · 2025-11-12 | Rexulti | $15 |
| Alkermes | Meals · 2025-11-10 | Aristada | $23 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-11-03 | Caplyta | $34 |
| Axsome Therapeutics | Meals · 2025-10-28 | Auvelity | $25 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-10-21 | Caplyta | $28 |
| Vanda Pharmaceuticals | Meals · 2025-10-15 | Fanapt | $28 |
| Abbvie | Meals · 2025-10-07 | Vraylar | $22 |
| Axsome Therapeutics | Meals · 2025-10-01 | Auvelity | $16 |
| Abbvie | Meals · 2025-09-29 | Vraylar | $3 |
| Abbvie | Meals · 2025-09-29 | Vraylar | $8 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-09-29 | Trintellix | $19 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-09-09 | Caplyta | $35 |
| Vanda Pharmaceuticals | Meals · 2025-09-06 | Fanapt | $20 |
| Abbvie | Meals · 2025-09-02 | Vraylar | $11 |
| Otsuka America Pharmaceutical | Meals · 2025-08-25 | Rexulti | $32 |
| Alkermes | Meals · 2025-08-19 | Lybalvi | $26 |
| Vanda Pharmaceuticals | Meals · 2025-08-19 | Fanapt | $17 |
| Abbvie | Meals · 2025-08-12 | Vraylar | $7 |
| Abbvie | Meals · 2025-08-07 | Vraylar | $124 |
| Vanda Pharmaceuticals | Meals · 2025-08-05 | Fanapt | $13 |
| Collegium Pharmaceutical | Meals · 2025-08-04 | Jornay Pm | $19 |
| Alkermes | Meals · 2025-07-31 | Lybalvi | $118 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-07-29 | Caplyta | $26 |
| Abbvie | Meals · 2025-07-21 | Vraylar | $13 |
| Abbvie | Meals · 2025-07-21 | Vraylar | $2 |
| Vanda Pharmaceuticals | Meals · 2025-07-18 | Fanapt | $11 |
| Abbvie | Meals · 2025-07-15 | Vraylar | $33 |
| Axsome Therapeutics | Meals · 2025-07-15 | Auvelity | $15 |
| Abbvie | Meals · 2025-07-10 | Vraylar | $10 |
| Otsuka America Pharmaceutical | Meals · 2025-06-30 | Rexulti | $30 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-06-25 | Caplyta | $1 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-06-25 | Caplyta | $10 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-06-25 | Caplyta | $105 |
| Vanda Pharmaceuticals | Meals · 2025-06-24 | Fanapt | $9 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-06-23 | Trintellix | $18 |
| Vanda Pharmaceuticals | Meals · 2025-06-17 | Fanapt | $13 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-06-17 | Caplyta | $35 |
| Abbvie | Meals · 2025-06-10 | Vraylar | $28 |
| Vanda Pharmaceuticals | Meals · 2025-06-10 | Fanapt | $9 |
| Abbvie | Meals · 2025-06-03 | Vraylar | $7 |
| Abbvie | Meals · 2025-06-03 | Vraylar | $19 |
| Abbvie | Meals · 2025-06-02 | Vraylar | $18 |
| Vanda Pharmaceuticals | Meals · 2025-05-20 | Fanapt | $32 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-05-20 | Caplyta | $8 |
| Abbvie | Meals · 2025-05-19 | Vraylar | $9 |
| Alkermes | Meals · 2025-05-12 | Aristada | $26 |
| Axsome Therapeutics | Meals · 2025-05-06 | Auvelity | $31 |
| Abbvie | Meals · 2025-04-30 | Vraylar | $7 |
| Abbvie | Meals · 2025-04-15 | Vraylar | $24 |
| Vanda Pharmaceuticals | Meals · 2025-04-15 | Fanapt | $29 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-04-11 | Caplyta | $20 |
| Abbvie | Meals · 2025-04-08 | Vraylar | $21 |
| Axsome Therapeutics | Meals · 2025-04-01 | Auvelity | $35 |
| Abbvie | Meals · 2025-03-27 | Vraylar | $8 |
| Axsome Therapeutics | Meals · 2025-03-26 | Auvelity | $30 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-03-24 | Caplyta | $26 |
| Abbvie | Meals · 2025-03-19 | Vraylar | $5 |
| Alkermes | Meals · 2025-03-17 | Lybalvi | $18 |
| Axsome Therapeutics | Meals · 2025-03-11 | Auvelity | $34 |
| Abbvie | Meals · 2025-03-05 | Vraylar | $6 |
| Lundbeck | Meals · 2025-03-03 | Rexulti | $30 |
| Abbvie | Meals · 2025-02-26 | Vraylar | $14 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-02-10 | Caplyta | $31 |
| Abbvie | Meals · 2025-02-05 | Vraylar | $5 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-02-03 | Trintellix | $33 |
| Vanda Pharmaceuticals | Meals · 2025-01-20 | Fanapt | $20 |
| Abbvie | Meals · 2025-01-17 | Vraylar | $10 |
| Abbvie | Meals · 2025-01-16 | Vraylar | $11 |
| Lundbeck | Meals · 2025-01-13 | Rexulti | $22 |
| Abbvie | Meals · 2025-01-08 | Vraylar | $5 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $1,531
| Abbvie | Vraylar | $393 | 23 payments
|
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Caplyta | $246 | 7 payments
|
| Alkermes | Lybalvi | $244 | 7 payments
|
| Brainsway USA | Brainsway Deep Tms System | $97 | 1 payment
|
| Supernus Pharmaceuticals | Qelbree | $95 | 2 payments
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $94 | 4 payments
|
| Corium | Azstarys | $89 | 4 payments
|
| Lundbeck | Rexulti | $73 | 3 payments
|
| Bausch Health US | Aplenzin | $59 | 3 payments
|
| Janssen Pharmaceuticals | Spravato | $51 | 2 payments
|
| Otsuka America Pharmaceutical | Rexulti | $26 | 1 payment
|
| Ironshore Pharmaceuticals | Jornay Pm | $23 | 1 payment
|
| Axsome Therapeutics | Auvelity | $23 | 1 payment
|
| Idorsia Pharmaceuticals US | Quviviq | $19 | 1 payment
|
2023: $1,114
| Abbvie | Vraylar | $273 | 20 payments
|
| Alkermes | Lybalvi | $193 | 4 payments
|
| Iti | Caplyta | $142 | 7 payments
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $134 | 5 payments
|
| Janssen Pharmaceuticals | Spravato | $98 | 4 payments
|
| Lundbeck | Abilify Asimtufii | $60 | 3 payments
|
| Idorsia Pharmaceuticals US | Quviviq | $57 | 3 payments
|
| Supernus Pharmaceuticals | Qelbree | $45 | 2 payments
|
| Bausch Health US | Aplenzin | $32 | 2 payments
|
| Otsuka America Pharmaceutical | Abilify Asimtufii | $30 | 1 payment
|
| Neurocrine Biosciences | Ingrezza | $28 | 1 payment
|
| Tris Pharma | Dyanavel Xr | $22 | 1 payment
|
2022: $1,373
| Abbvie | Vraylar | $344 | 28 payments
|
| Lundbeck | Rexulti | $263 | 14 payments
|
| Iti | Caplyta | $237 | 6 payments
|
| Sunovion Pharmaceuticals | Latuda | $105 | 8 payments
|
| Supernus Pharmaceuticals | Qelbree | $94 | 5 payments
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $80 | 3 payments
|
| Neurocrine Biosciences | Ingrezza | $76 | 3 payments
|
| Alkermes | Aristada | $71 | 3 payments
|
| Otsuka America Pharmaceutical | Rexulti | $50 | 2 payments
|
| Tris Pharma | Dyanavel Xr | $34 | 2 payments
|
| Bausch Health US | Aplenzin | $20 | 1 payment
|
2021: $938
| AbbVie | Vraylar | $210 | 14 payments
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $160 | 8 payments
|
| Lundbeck | Rexulti | $150 | 8 payments
|
| Otsuka America Pharmaceutical | Rexulti | $99 | 5 payments
|
| Iti | Caplyta | $84 | 2 payments
|
| Bausch Health US | Aplenzin | $71 | 3 payments
|
| Sunovion Pharmaceuticals | Latuda | $44 | 2 payments
|
| Neurocrine Biosciences | Ingrezza | $43 | 2 payments
|
| Supernus Pharmaceuticals | Qelbree | $41 | 2 payments
|
| Eisai | Dayvigo | $21 | 1 payment
|
| Tris Pharma | Dyanavel Xr | $16 | 1 payment
|
2020: $790
| Sunovion Pharmaceuticals | Latuda | $149 | 7 payments
|
| Allergan | Vraylar | $131 | 14 payments
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $111 | 7 payments
|
| Lundbeck | Rexulti | $107 | 7 payments
|
| Otsuka America Pharmaceutical | Rexulti | $105 | 5 payments
|
| Iti | Caplyta | $81 | 3 payments
|
| Ironshore Pharmaceuticals | Jornay Pm | $53 | 3 payments
|
| Arbor Pharmaceuticals | Evekeo Odt | $21 | 1 payment
|
| Janssen Pharmaceuticals | Spravato | $20 | 1 payment
|
| Bausch Health US | Aplenzin | $13 | 1 payment
|
2019: $832
| Otsuka America Pharmaceutical | Rexulti | $373 | 14 payments
|
| Ironshore Pharmaceuticals | Jornay Pm 20mg Capsules (Bottle of 100) | $117 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $74 | 5 payments
|
| Shire North American Group | Vyvanse | $61 | 4 payments
|
| Allergan | Vraylar | $59 | 4 payments
|
| Neurocrine Biosciences | Ingrezza | $37 | 2 payments
|
| Vertical Pharmaceuticals | Osmolex Er | $35 | 2 payments
|
| Lundbeck | Rexulti | $31 | 2 payments
|
| Bausch Health US | Aplenzin | $28 | 2 payments
|
| Sunovion Pharmaceuticals | Latuda | $18 | 1 payment
|
Professional record
- NPI
- 1093904005
- Licence
- CA G69058California G69058: Current · expires 2028-06-30
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 2084P0804X (2084P0804X); Psychiatry (2084P0800X)
- Mailing address
- 15215 National Avenue, Suite 101, Los Gatos, CA, 95032
- NPI first listed
- 2007-10-16
- NPI last updated
- 2024-09-06
This is when the NPI record was last certified, not a medical board exam.